
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
Episodes
Tuesday Apr 05, 2022
Melanoma is Becoming Easier to Treat
Tuesday Apr 05, 2022
Tuesday Apr 05, 2022
Melanoma used to be really scary! Leading cancer researcher Keith Flaherty tells us how melanoma is actually becoming easier to treat. Keith has been working in cancer research for over 22 years, from UPenn to Mass General and Harvard Medical School. He has been one of the pioneers of immunotherapies specifically related to melanoma. In this episode, Keith and Sanjay talk about the different types of immunotherapies, why melanoma used to be so life-threatening, and how the newest treatments coming out could really change the way patients and doctors approach melanoma and cancer as a whole.

No comments yet. Be the first to say something!